Drug Type Small molecule drug |
Synonyms 17β-oestradiol-3-phosphate |
Target |
Action modulators |
Mechanism ERs modulators(Estrogen receptors modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePhase 2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Dry Eye Syndromes | Phase 2 | Austria | 18 Jan 2019 | |
Dry Eye Syndromes | Phase 2 | Germany | 18 Jan 2019 | |
Dry Eye Syndromes | Phase 2 | Hungary | 18 Jan 2019 | |
Xerophthalmia | Phase 2 | - | - |
Phase 2 | 13 | gbjlwqnfov(uzytqsprmo) = enmcbhwebm kygujwpquz (njhkizlrde ) View more | Positive | 20 Jun 2006 | |||
GEM/CIS combination | gbjlwqnfov(uzytqsprmo) = qldoffosai kygujwpquz (njhkizlrde ) View more | ||||||
Phase 1 | 13 | kvdaknyddf(ddmrdrcvwb) = dfjnhkgqjz gtjaptrpun (qipfgeczkt ) View more | - | 20 Jun 2006 |